HOANG DUC PHARMACEUTICAL & MEDICAL SUPPLIES CO., LTD (Công Ty TNHH Dược Phẩm và Trang Thiết Bị Y Tế Hoàng Đức) is a privately owned enterprise with nearly three decades of experience in Vietnam’s pharmaceutical and healthcare distribution industry. Established in 1995 and headquartered in District 3, Ho Chi Minh City, the company has built a strong national footprint, with branches in Hanoi, Da Nang, and Long An Province. Its core business includes importing and distributing pharmaceuticals, vaccines, medical equipment, nutritional supplements, and biological products.
The company’s financial results for 2023 reflect a classic case of top-line growth outpacing bottom-line performance. Total revenue surged by 44.78% year-over-year to USD 216.59 million, and assets rose to USD 106.05 million, an 8.19% increase. However, profit collapsed by nearly 85%, falling to just USD 66,714. This indicates severe margin erosion, likely due to pricing pressure, increased costs of goods sold, or inefficiencies in operational scaling.
Equity remained relatively stable at USD 12.89 million, and working capital stood at USD 4.79 million, suggesting that liquidity has been preserved. Yet the steep decline in profitability may raise concerns for stakeholders about sustainability, especially as the company continues to expand its reach across Vietnam’s healthcare infrastructure.
HOANG DUC is led by Mr. Dang Van Tuong, who also holds a 50% ownership stake. He is joined by Mr. Nguyen Vu Hoang Trung (26%) and Ms. Vu Hoang Yen (24%)—all of whom appear to be family members or close affiliates, underscoring the family-run nature of the business. While the leadership has successfully scaled the company’s revenue and built strategic relationships in the healthcare supply chain, the dramatic drop in net income suggests a need for stronger financial oversight and cost control.
Despite the recent profit slump, the company’s long history, nationwide operations, and consistent revenue growth keep it firmly positioned in the market. However, without a rebound in profitability, future expansions may become financially strained or strategically riskier.
For those looking to assess the financial health, legal standing, or business credibility of HOANG DUC PHARMACEUTICAL & MEDICAL SUPPLIES CO., LTD or other Vietnamese firms, detailed corporate reports are available at VANGUARD BUSINESS INFORMATION LLC (VBI), Vietnam’s trusted provider of company verification and risk analysis services.
+ DANG V.T
+ NGUYEN V.H.T
+ DOAN T.L
4.34%
8.09%
66,687
2.2993%
Assets | 83.43% |
Owner’s Equity | -33.18% |
Working Capital | -3.34% |
Net Worth | -39.90% |
Sales | -72.88% |
Operating income | -19.18% |
EBIT | 33.34% |
Gross Profit Margin | -31.01% |
Debt to EBITDA | 80.43% |
Legal Profile
Contact and Location
Legal Representative
Shareholders
Business Operation
Assets
Owner's Equity
Sales
Profit
Legal Profile
Business Locations
Legal Representative
EBT
EBITDA
Working Capital
Tangible Net Worth
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Report Summary
Legal Profile
Historical Information
Business Locations
Subsidiary and Affiliated Company
Management and Directors
Shareholders
Business Operation
Suppliers
Buyers
Credit Limit
Industry Information
Key Industry Players
Competitors
Negative Payment Records
Banking Information
Litigation Records; Negative News
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Opinion from Analysts
Partner with VNBIS for reliable, verified and up to date information